建議您使用以下瀏覽器觀看本網站，
以獲得最佳瀏覽效果。
Scientific Advisory Boards
Chairman - Da-Wen Lu, Professor, M.D., Ph.D.
More than 30 years of clinical research experience in ophthalmology
Education
- M.D., Department of Medicine, National Defense Medical Center
- Ph.D., Institute of Medical Sciences, National Defense Medical Center
Current Job
- Director, General Ophthalmology Department, Tri-Service General Hospital
- Director, Department of Glaucoma, Tri-Service General Hospital
- Professor, Department of Ophthalmology, National Defense Medical Center
- Chairman, Taiwan association for relief of glaucoma and effective therapy
Experience
- Associate professor, Pennsylvania Wills Eye Hospital
- Chairman, Taiwan Academy of Facial Plastic and Reconstructive Surgery
- International member, American Academy of Ophthalmology
- Academician, European Academy of Glaucoma
- Director, Department of Ophthalmology of the Tri-Services General Hospital
- Executive director, World Glaucoma Summit
- Executive director, Asia Pacific Glaucoma Society
- Executive director, Ophthalmological Society of Taiwan
- Executive director, Taiwan Academy of Facial Plastic and Reconstructive Surgery
Cheng-Kuo, Cheng, Associate Professor, M.D.
More than 30 years of clinical research experience in ophthalmology
Education
- M.D., Department of Medicine, National Taiwan University
Current Job
- Director, Department of ophthalmology and Retina Center of Shin Kong Hospital
- Executive Director, Taiwan Retina Society
- Associate Professor, Department of Medicine, Fu Jen Catholic University
- Director, Department of Ophthalmology, Fu Jen Catholic University
- Adjunct Assistant Professor, Department of Medicine, National Taiwan University
Experience
- Research fellow, Eye center, Duke University
- Director, Taiwan Retina Society
- Associate editor, Taiwan Journal of Ophthalmology
Jr-Rung Lin, Associate Professor, Ph.D.
More than 20 years of experience in clinical trial design and medical biostatistics
Education
- Ph.D., Biostatistics, National Taiwan University
Current Job
- Associate professor, Clinical Informatics and Medical Statistics Research Center, Chang Gung University
- Associate professor, Institute of Clinical Medical Sciences, Chang Gung University.
- Executive secretary and Member, Data and Safety Monitoring Committee, Clinical Trial Center of the Lin-kou Branch of Chang Gung Memorial Hospital.
- Convenor, Clinical Trial Research Program, Chang Gung University
- Instructor, JIRB's GCP and Human Research Ethics Seminar
- Reviewer, Human Trials Committee (Institutional Review Board, IRB)
Experience
- Consultant, Resource Center for Clinical Research, Chang Gung Memorial Hospital
- Postdoctoral researcher, Statistics Education Center, National Taiwan University
- Biostatistician, Clinical Research Lab/Division of Biostatistics, Koo Foundation Sun Yat-Sen Cancer Center
Hong-Jaan Wang, Associate Professor, Ph.D.
More than 20 years of experience in pharmacokinetics research
Education
- Ph.D., Institute of Life Sciences, National Defense Medical Center
Current Job
- Director, Department of Pharmacy, National Defense Medical Center
- Co-professor of PK analysis, Clinical trial, Metagone Biotechnology
- Scientific consultant, Sinew Pharma Inc.
- Deputy and the editorial board, Chinese Pharmacopoeia
Experience
- Visiting scholar, University of California, San Francisco.
Akaphot Thongmee (Mark), M.D.,
More than 10 years of medical advisor experience at multinational pharmaceutical companies
Dr. Mark Thongmee, M.D., MRCP (UK), is a translational research physician trained in Translational Medicine and Early Phase Development from Imperial College London. With over a decade of experience, he has contributed significantly to clinical trials in infectious diseases and oncology across Southeast Asia, including leading community-based trials for HIV and HCV. He has spearheaded numerous research trials and medical initiatives, notably as;
- Global Medical Affairs lead at GPCRO Contract Research Organisation, leading the clinical trial designed and medical monitor for oncology, ophthalmology, COVID-19 infection, and gene therapy.
- Country Medical Director at Amgen and Allergan, he bridged clinical research with strategic medical affairs, enhanced drug accessibility, and implemented health economic outcomes research (HEOR) to support reimbursement strategies.
